Menopausal Status as an Effect Modifier of the Association Between Adiposity, Insulin Resistance, and Bone Mineral Density: A Narrative Review
International Journal of Molecular Sciences · 20.11.2026 · 27 (22) · 10461
DOI: 10.3390/ijms272210461 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.11.2026. Verfasst von Vitaly V. Gursky und 6 weiteren Autor:innen. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Osteoporosis is a major health burden, with estrogen deficiency after menopause as its primary cause. Whether obesity, insulin resistance, and type 2 diabetes mellitus (T2DM) relate to bone mineral density (BMD) similarly before and after menopause remains unclear. Because “obesity” encompasses distinct exposures, we distinguished general, central/visceral, subcutaneous/fat distribution, and lean-mass phenotypes. We searched PubMed (2016–2026) for studies analyzing women with obesity, insulin resistance, or T2DM; assessing BMD, osteoporosis, or fracture risk; and including both pre- and postmenopausal women as subgroups or comparing results by menopausal status. From 1884 records obtained by the database search, 14 studies met the criteria, including approximately 2.55 million women, with pre- and postmenopausal women split almost equally. In premenopausal women, visceral adipose tissue, body fat percentage, elevated HOMA-IR, and central obesity were associated with low BMD. In postmenopausal women, lean mass loss (sarcopenia), subcutaneous adipose tissue dis-tribution, metabolic syndrome components, and adipokine dysregulation were among the factors associated with low BMD. Regional fat deports showed differing associations with BMD across menopause, although these findings derive largely from single studies or small subgroups. Metabolic disorder–BMD relationships are modified by menopausal status: visceral adiposity is consistently associated with lower premenopausal BMD, whereas sarcopenic obesity and adipokine imbalance are associated with postmenopausal bone loss. These findings require confirmation by longitudinal and interventional studies but provide a biologically plausible basis for menopausal-specific risk-assessment hypotheses.
Förderung
- Russian Science Foundation
Zitieren
APA
Gursky, V. V., Sopova, J. V., Isaenko, A. Y., Krasnova, O. A., Shmidt, E. V., Lesnyak, O. M., & Neganova, I. E. (2026). Menopausal Status as an Effect Modifier of the Association Between Adiposity, Insulin Resistance, and Bone Mineral Density: A Narrative Review. International Journal of Molecular Sciences, 27(22), 10461. https://doi.org/10.3390/ijms272210461
Vancouver
Gursky VV, Sopova JV, Isaenko AY, Krasnova OA, Shmidt EV, Lesnyak OM, et al. Menopausal Status as an Effect Modifier of the Association Between Adiposity, Insulin Resistance, and Bone Mineral Density: A Narrative Review. International Journal of Molecular Sciences. 2026;27(22):10461. doi:10.3390/ijms272210461
BibTeX
@article{Gursky2026,
author = {Gursky, Vitaly V. and Sopova, Julia V. and Isaenko, Anton Y. and Krasnova, Olga A. and Shmidt, Elena V. and Lesnyak, Olga M. and Neganova, Irina E.},
title = {Menopausal Status as an Effect Modifier of the Association Between Adiposity, Insulin Resistance, and Bone Mineral Density: A Narrative Review},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10461},
doi = {10.3390/ijms272210461}
}
EUVIMED